A new study has found that moderate increases in blood pressure and cholesterol have a greater impact on arterial plaque, or atherosclerosis, progression in 40-year-olds than in people over 48. The ...

Preclinical data suggest neratinib dampens vascular inflammation and atherosclerosis by targeting ASK1 in endothelial cells, ...

In a recent study published in Nature Cardiovascular Research, researchers assessed T-cell tolerance checkpoints observed in atherosclerosis. Study: Pairing of single-cell RNA analysis and T cell ...

Neratinib, an oral drug commonly used in the treatment of breast cancer, has shown potential in reducing vascular ...

Individuals in the general population with high levels of silent coronary atherosclerosis can be successfully identified with a simple questionnaire that they can complete themselves at home, a new ...

University of Virginia (UVA) School of Medicine researchers have created an atlas of atherosclerosis that reveals, at the level of individual cells, critical processes responsible for forming the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers in Sweden reported that atherosclerosis was ...

Subclinical atherosclerosis progressed in about one-third of healthy, middle-aged individuals followed for 6 years in the Progression of Early Subclinical Atherosclerosis (PESA) study, but ...

Atherosclerosis -- hardening of the arteries -- is now involved in the majority of deaths worldwide, and advances in our understanding of the biology of the disease are changing traditional views and ...